WHO Weekly Epidemiological Record (WER) – 18 September 2015, Vol. 90, 38
16 pp. 601 kB
Lymphatic filariasis (LF) is targeted for global elimination as a public health problem by 2020. The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in 2000, aiming to stop the spread of infection and alleviate suffering. Mass drug administration (MDA) is the recommended preventive chemotherapy (PC) strategy of delivering safe, anthelminthic drugs to populations at risk of LF to prevent morbidity due to infection and interrupt transmission. When the level of infection has been reduced to below target thresholds, MDA is considered no longer required.